S. Richter

发表

Sensitive and efficient detection of RB1 gene mutations enhances care for families with retinoblastoma.

Brenda Gallie, B. Gallie, S. Richter, 2003, American journal of human genetics.

Management of small cell carcinoma of the bladder: Consensus guidelines from the Canadian Association of Genitourinary Medical Oncologists (CAGMO).

P. Black, A. Eisen, I. Cagiannos, 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Her-2/neu expression in testicular cancer--a retrospective analysis in 57 cases.

A. Heidenreich, S. Richter, T. Klotz, 2010, Urology.

Predictors of cisplatin-induced ototoxicity and survival in chemoradiation treated head and neck cancer patients.

R. Kim, D. Palma, S. Welch, 2019, Oral oncology.

Practice patterns and perceptions of survivorship care in Canadian genitourinary oncology: A multidisciplinary perspective.

M. Maganti, M. Jewett, S. Sridhar, 2014, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Current Options and Future Directions in Castrate Resistant Prostate (CRPC)

S. Sridhar, S. Richter, 2011 .

A phase I study of the oral gamma secretase inhibitor R04929097 in combination with gemcitabine in patients with advanced solid tumors (PHL-078/CTEP 8575)

A. Oza, B. Clarke, H. Hirte, 2013, Investigational New Drugs.

Management of carcinoma of the penis: Consensus statement from the Canadian Association of Genitourinary Medical Oncologists (CAGMO).

J. Crook, A. Eisen, N. Fleshner, 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Results of a randomized controlled study of personalized care plans in breast cancer survivors from a single institution.

S. Richter, A. Jovicic, F. Leung, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Fecal DNA screening in colorectal cancer.

S. Richter, 2008, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

Variants of unknown significance in BRCA testing: impact on risk perception, worry, prevention and counseling.

A. Kiss, E. Warner, A. Eisen, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Abstract 1112: Feasibility of real-time personalized patient-derived Tumorgraft®models for guiding systemic treatment in recurrent and/or metastatic head and neck cancer patients

K. Fung, D. Palma, A. Berger, 2020 .

Occult calcified breast lesions

S. Richter, M. Säbel, H. Rosenthal, 1993, European Radiology.

New Directions for Biologic Targets in Urothelial Carcinoma

S. Sridhar, S. Richter, 2012, Molecular Cancer Therapeutics.

Feasibility of Targeting PIK3CA Mutations in Head and Neck Squamous Cell Carcinoma

K. Fung, D. Palma, J. Theurer, 2015, Pathology & Oncology Research.

One step direct detection of recurrent mutations in the breast cancer susceptibility gene, BRCA1.

S. Richter, A. Seth, 1998, International journal of oncology.

New Directions for Biologic Targets in Urothelial Carcinoma – Response

S. Sridhar, S. Richter, 2012, Molecular Cancer Therapeutics.

A phase 1 study of SNS-032 (formerly BMS-387032), a potent inhibitor of cyclin-dependent kinases 2, 7 and 9 administered as a single oral dose and weekly infusion in patients with metastatic refractory solid tumors

Patricia M. LoRusso, Percy, A. Oza, 2008, Investigational New Drugs.

Her-2/neu expression in testicular cancer--a retrospective analysis in 57 cases.

S. Richter, T. Klotz, D. Pfister, 2010, Urology.

Management of small cell carcinoma of the bladder: Consensus guidelines from the Canadian Association of Genitourinary Medical Oncologists (CAGMO).

P. Black, A. Eisen, I. Cagiannos, 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

New Directions for Biologic Targets in Urothelial Carcinoma

S. Sridhar, S. Richter, 2012, Molecular Cancer Therapeutics.